Prolonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancer

Cancer Research

Volumn 67, Issue 22, 2007, Pages 10766-10773

  Santiago, Cariluz ^a   Pagán, Beatriz ^a   Isidro, Angel A ^a   Appleyard, Caroline B ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE; SULFONIC ACID DERIVATIVE; TRINITROBENZENESULFONIC ACID;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC INFLAMMATION; COLITIS; COLON CANCER; CONTROLLED STUDY; DYSPLASIA; EXON; GENE MUTATION; GENETIC ANALYSIS; INCIDENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PRIORITY JOURNAL; RAT;

1,2-DIMETHYLHYDRAZINE; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CARCINOMA; CHRONIC DISEASE; COLITIS; COLONIC NEOPLASMS; EXONS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MUTATION; RATS; TIME FACTORS; TRINITROBENZENESULFONIC ACID; TUMOR SUPPRESSOR PROTEIN P53;

EID: 36349022817     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1418     Document Type: Article

References (45)

1. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004;126:1518-32.
2. Elson CO, Balfour-Sartor R, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
3. Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, β-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000;21:757-68.
4. Greenstein AJ. Cancer in inflammatory bowel disease. Mt Sinai J Med 2000;67:227-40.
5. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
6. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel disease. Gastroenterology 2004;126:1634-48.
7. Chaubert P, Benhattar J, Saraga E, Costa J. K-ras mutations and p53 alterations in neoplastic and non-neoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994;144:767-75.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
9. Fodde R. The APC gene in colorectal cancer. Eur J Cancer 2002;38:867-71.
10. Powrie F, Leach MW. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther Immunol 1995;2:115-23.
11. Berg DJ, Zhang J, Weinstock JV, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 2002;123:1527-42.
12. Sadlack B, Merz H, Schorle H, Schimpi A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
13. Pozharisski KM, Kapustin YM, Likhachev AJ, Shaposhnikov JD. The mechanism of carcinogenic action of 1,2-dimethylhydrazine (SDMH) in rats. Int J Cancer 1975;15:673-83.
14. Fiala E. Investigations into the metabolism and mode of action of the colon carcinogen 1, 2-dimethylhydrazine. Cancer 1975;36:2407-12.
15. Koesters R, Hans MA, Benner A, et al. Predominant mutation of codon 41 of the β-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. Carcinogenesis 2001;22:1885-90.
16. O'Connell J, Maggard M. Colon cancer survival rates with the New American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 2004;96:1420-5.
17. Guerra C, Mijimolle N, Dhawahir A, et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 2003;4:111-20.
18. Meyer E, Vollmer JY, Bovey R, Stamenkovic I. Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis. Cancer Res 2005;65:4261-72.
19. Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 1995;269:G119-25.
20. Appleyard CB, Morales M, Santiago C. Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon. Dig Dis Sci. Epub 2007 May 18.
21. Hernandez GA, Valentin MR, Appleyard CB. Effect of bacterial chemotactic peptides on intestinal inflammation in animal models of acute and chronic relapsed colitis. Dig Dis Sci 2005;8:1444-53.
22. Hernandez GA, Appleyard CB. Bacterial load in animal models of acute and chronic "reactivated" colitis. Digestion 2003;3:161-9.
23. Sun FF, Pi-Shiang L, Yue G, et al. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation 2001;25:33-45.
24. Qing-Yong M, Williamson KE, Rowlands BJ. Variability of cell proliferation in the proximal and distal colon of normal rats and rats with dimethylhydrazine induced carcinogenesis. World J Gastroenterol 2002;8:847-52.
25. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: Consensus report and recommendations. Gastroenterology 2003;124:762-77.
26. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN, Lantz PE, Listrom MB, Rilke FO. Inflammatory Bowel Disease. 2nd ed. In: Gastrointestinal Pathology, an Atlas and Text. Philadelphia (PA): Lippincott Williams & Wilkins; 1999. p. 631-716.
27. Sohn KJ, Puchyr M, Salomon RN, et al. The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer. Carcinogenesis 1999;20:2345-50.
28. McCole DF, Rogler G, Varki N, Barrett KE. Epidermal growth factor partially restores colonic ion transport responses in mouse models of chronic colitis. Gastroenterology 2005;129:591-608.
29. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
30. McGarrity TJ, Peiffer LP, Colony PC. Cellular proliferation in proximal and distal rat colon during 1,2-dimethylhydrazine-induced carcinogenesis. Gastroenterology 1988;95:343-8.
31. Mitamura T, Sakamoto S, Sassa S, Suzuiki S, Kudo H, Okayasu I. The more an ulcerative colitis is repeated, the more the risk of colorectal carcinogenesis is increased in mice. Anticancer Res 2002;22:3955-61.
32. Takeda J, Kitajima K, Fujii S, et al. Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats. Oncol Rep 2004;11:981-5.
33. Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996;39:87-92.
34. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004;95:475-80.
35. Cooper HS, Everley L, Chang WC, et al. The role of mutant APC in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis. Gastroenterology 2001;121:1407-16.
36. Kullmann F, Messmann H, Alt M, et al. Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats. Int J Colorectal Dis 2001;16:238-46.
37. Brentnall TA, Crispin DA, Rabinovitch PS, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369-78.
38. Chaubert P, Benhattar J, Saraga E, Cota J. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994;144:767-75.
39. Holzmann K, Klump B, Borchard F, et al. Comparative analysis of histology, DNA content p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int J Cancer 1998;76:1-6.
40. Tarmin L, Yin J, Harpaz N, et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 1995;55:2035-8.
41. Buyse IM, Fang P, Hoon KT, Amir RE, Zoghbi HY, Roa BB. Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. Am J Hum Genet 2000;67:1428-36.
42. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y. Colorectal cancer: genetics of development and metastasis. J Gastroenterol 2006;41:185-92.
43. Sipos F, Molnar B, Zagoni T, Berczi L, Tulassay Z. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53 and EGFR expression alterations. Dis Colon Rectum 2005;48:775-86.
44. Castagliuolo I, Morteau O, Keates AC, et al. Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor. Br J Pharmacol 2002;136:271-9.
45. Zamuner SR, Warrier N, Buret AG, MacNaughton WK, Wallace JL. Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut 2003;52:1714-20.